Behavioral versus drug treatment for overactive bladder in men: The male overactive bladder treatment in veterans (MOTIVE) trial

Journal of the American Geriatrics Society

Volumn 59, Issue 12, 2011, Pages 2209-2216

  Burgio, Kathryn L ^a,b   Goode, Patricia S ^a,b   Johnson, Theodore M ^a,e   Hammontree, Lee ^a,c   Ouslander, Joseph G ^f   Markland, Alayne D ^a,b   Colli, Janet ^a,c   Vaughan, Camille P ^a,e   Redden, David T ^a,d  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c Kentucky   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e EMORY UNIVERSITY   (United States)

^f FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

behavioral treatment; drug therapy; lower urinary tract symptoms; overactive bladder; urinary incontinence

Indexed keywords

ALFUZOSIN; DOXAZOSIN; OXYBUTYNIN; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; DELAYED VOIDING; DRUG DOSE ESCALATION; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; MICTURITION; NOCTURIA; OVERACTIVE BLADDER; PATIENT SATISFACTION; PELVIC FLOOR MUSCLE TRAINING; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URGE SUPPRESSION TECHNIQUE; URINARY URGENCY;

BEHAVIOR THERAPY; HUMANS; MALE; MANDELIC ACIDS; MIDDLE AGED; MUSCARINIC ANTAGONISTS; URINARY BLADDER, OVERACTIVE; VETERANS;

EID: 84155170709     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03724.x     Document Type: Article

References (39)

1. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760-766. (Pubitemid 34204313)
2. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-336. (Pubitemid 44175300)
3. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306.
4. Ouslander JG,. Management of overactive bladder. N Engl J Med 2004; 350: 786-799. (Pubitemid 38209648)
5. Andersson KE, Chapple CR, Cardozo L, et al. Pharmacological treatment of urinary incontinence. In:, Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence, 4th Ed. 4th International Consultation on Incontinence. Paris: Health Publication Ltd., 2009, pp 631-699
6. Hartmann K, Mcpheeters M, Biller D, et al. Treatment of overactive bladder in women. Evidence Report/Technology Assessment No.187 (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2007-10065-I) AHRQ Publication No. 09-E017. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
7. Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial. JAMA 2006; 296: 2319-2328. (Pubitemid 44749359)
8. MacDiarmid SA, Peters KM, Chen A, et al. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: Randomized, double-blind, placebo-controlled study. Mayo Clin Proc 2008; 83: 1002-1010.
9. Chapple C, Herschorn S, Abrams P, et al. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol 2009; 56: 534-543.
10. Kaplan SA, McCammon K, Fincher R, et al. Safety and tolerability of solifenancin add-on therapy to alpha-blocker treated men with residual urgency and frequency. J Urol 2009; 182: 2826-2830.
11. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-2398. (Pubitemid 37542987)
12. Sears CL, Lewis C, Noel K, et al. Overactive bladder medication adherence when medication is free to patients. J Urol 2010; 183: 1077-1078.
13. Pelletier EM, Vats V, Clemens JQ,. Pharmacotherapy adherence and costs versus nonpharmacologic management in overactive bladder. Am J Manag Care 2009; 15: S108-S114.
14. Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid program. Value Health 2005; 8: 495-505. (Pubitemid 41726103)
15. Hay-Smith J, Berghmans B, Burgio K, et al. Adult conservative management. In:, Abrams P, Cardozo L, Khoury S, Wein A, eds. Incontinence. 4th Ed. 4th International Consultation on Incontinence. Paris: Health Publication Ltd., 2009, pp 1025-1120.
16. Fantl JA, Wyman JF, McClish DK, et al. Efficacy of bladder training in older women with urinary incontinence. JAMA 1991; 265: 609-613.
17. Burgio KL, Locher JL, Goode PS, et al. Behavioral versus drug treatment for urge incontinence in older women: A randomized clinical trial. JAMA 1998; 23: 1995-2000.
18. Wyman JF, Fantl JA, McClish DK, et al. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Am J Obstet Gynecol 1998; 179: 999-1007. (Pubitemid 28489298)
19. Subak LL, Quesenberry CP, Posner SF, et al. The effect of behavioral therapy on urinary incontinence: A randomized controlled trial. Obstet Gynecol 2002; 100: 72-78. (Pubitemid 34722845)
20. Dougherty MC, Dwyer JW, Pendergast JF, et al. A randomized trial of behavioral management for continence with older rural women. Res Nurs Health 2002; 25: 3-13.
21. Burgio KL, Whitehead WE, Engel BT,. Urinary incontinence in the elderly: Bladder/sphincter biofeedback and toileting skills training. Ann Intern Med 1985; 103: 507-515.
22. Brown CT, Yap T, Cromwell DA, et al. Self-management for men with lower urinary tract symptoms: Randomised controlled trial. BMJ 2007; 334: 25-28. (Pubitemid 46095444)
23. Yap TL, Brown C, Cromwell DA, et al. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. BJU Int 2009; 104: 1104-1108.
24. Borson S, Scanlan J, Brush M, et al. The Mini-Cog: A cognitive "vital signs" measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 2000; 15: 1021-1027.
25. Folstein MF, Folstein SE, McHugh PR,. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189.
26. DuBeau CE, Yalla SV, Resnick NM,. Improving the utility of urine flow rate to exclude outlet obstruction in men with voiding symptoms. J Am Geriatr Soc 1998; 46: 1118-1124. (Pubitemid 28415601)
27. Dmochowski RR,. Bladder outlet obstruction: Etiology and evaluation. Rev Urol 2005; 7 (Suppl 6): S3-S13.
28. Locher JL, Roth DL, Goode PS, et al. Reliability assessment of the bladder diary for urinary incontinence in older women. J Gerontol A Biol Sci Med Sci 2001; 56A: M32.
29. Wyman JF, Choi SC, Harkins SW, et al. The urinary diary in evaluation of incontinent women: A test-retest analysis. Obstet Gynecol 1988; 71: 812-817.
30. Nixon A, Colman S, Sabounjian L, et al. A validated patient reported measure of urgency severity in overactive bladder for use in clinical trials. J Urol 2005; 174: 604-607. (Pubitemid 40981612)
31. Burgio KL, Goode PS, Richter HE, et al. Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: Validation of three global patient ratings. Neurourol Urodyn 2006; 25: 411.
32. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptoms index for benign prostatic hyperplasia. J Urol 1992a; 148: 1549-1557.
33. Phillips KF,. Power of the two-one-sided tests procedure in bioequivalence. J Pharmacokinet Biopharm 1990; 18: 137-144. (Pubitemid 20207826)
34. Schuirmann D,. A comparison of two-one-sided tests procedure and the power approach for assessing the equivalence of bioavailability. J Pharmacokinet Biopharm 1987; 15: 657-680.
35. Johnson TM, Burgio KL, Redden DT, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 2005; 53: 846-850. (Pubitemid 41656931)
36. McClish DK, Fantl JA, Wyman JF, et al. Bladder training in older women with urinary incontinence: Relationship between outcome and changes in urodynamic observations. Obstet Gynecol 1991; 77: 281-286.
37. Elser DM, Wyman JF, McClish DK, et al. The effect of bladder training, pelvic floor muscle training, or combination training on urodynamic parameters in women with urinary incontinence. Neurourol Urodyn 1999; 18: 427-436. (Pubitemid 29468394)
38. Goode PS, Burgio KL, Locher JL, et al. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women. J Am Geriatr Soc 2002; 50: 808-816. (Pubitemid 34496675)
39. Vaughan CP, Endeshaw Y, Nagamia Z, et al. A multicomponent behavioral and drug intervention for nocturia in elderly men: Rationale and pilot results. BJU Int 2009; 104: 69-74.